期刊
MICROBES AND INFECTION
卷 24, 期 3, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.micinf.2021.104928
关键词
Cationic antimicrobial peptides; Human lung epithelial cell lines; Pseudomonas aeruginosa; Bactericidal activity; Immunomodulatory activity
资金
- Fondation Air Liquide [S-CM19006]
- Association Les Motards du Viaduc de Millau
Cationic antimicrobial peptides (CAMPs) exert bactericidal effects against Pseudomonas aeruginosa (PA) depending on the timing of administration, with pretreatment of IB3-1 cells enhancing the bactericidal activity. LL-37 induces factors production in IB3-1 cells to improve bactericidal action.
Cationic antimicrobial peptides (CAMPs) are important actors in host innate immunity and represent a promising alternative to combat antibiotic resistance. Here, the bactericidal activity of two CAMPs (LL-37 and CAMA) was evaluated against Pseudomonas aeruginosa (PA) in the presence of IB3-1 cells, a cell line derived from patients with cystic fibrosis. The two CAMPs exerted different effects on PA survival depending on the timing of their administration. We observed a greater bactericidal effect when IB3-1 cells were pretreated with sub-minimum bactericidal concentrations (Sub-MBCs) of the CAMPs prior to infection. These findings suggest that CAMPs induce the production of factors by IB3-1 cells that improve their bactericidal action. However, we observed no bactericidal effect when supra-minimum bactericidal concentrations (Supra-MBCs) of the CAMPs were added to IB3-1 cells at the same time or after infection. Western-blot analysis showed a large decrease in LL-37 levels in supernatants of infected IB3-1 cells and an increase in LL-37 binding to these cells after LL-37 administration. LL-37 induced a weak inflammatory response in the cells without being toxic. In conclusion, our findings suggest a potential prophylactic action of CAMPs. The bactericidal effects were low when the CAMPs were added after cell infection, likely due to degradation of CAMPs by bacterial or epithelial cell proteases and/or due to adherence of CAMPs to cells becoming less available for direct bacterial killing. (C) 2022 The Authors. Published by Elsevier Masson SAS on behalf of Institut Pasteur.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据